论文部分内容阅读
乳酶生与抗生素联合用药,被认为是临床配伍禁忌,已屡有报道。举例如下: “痢特灵等抗菌药物与乳酶生并用……其活性将被抑制”〔樊德厚:中国医院药学杂志 3(1):16,1983〕。 “乳酶生与四环紊、土霉素等多种抗生素……合用,致使乳酶生失活”〔刘万根:中国医院药学杂志 3(2):63,1983〕。类似论述还散见于其它一些文献及教科书中。笔者认为上述的“并用”“合用”显然是指合并口服,但是如果在提法上不更加明确,将会造成临床用药上的混乱。乳酶生为活性乳酸杆菌的干燥制剂,口服给药后
Lactase Health and antibiotics in combination, is considered to be incompatibility of clinical compatibility, has been repeatedly reported. Examples are as follows: “Furazolidone and other antibiotics and lactase Health and its activity will be inhibited ” [Fan Dehou: Chinese Journal of Hospital Pharmacy 3 (1): 16,1983〕. “Lactase Health and tetracycline, oxytetracycline and other antibiotics ... ... combined, resulting in lactase Health inactivation ” [Liu Wangen: Chinese Hospital Pharmacy 3 (2): 63,1983〕. Similar discourses are also found in other texts and texts. The author believes that the above “use” and “co-use” obviously refers to the merger of oral, but if the reference is not more clear, it will cause confusion in clinical medication. Lactase raw Lactobacillus live dry preparations, after oral administration